ISOCARBOXAZID: 37 Adverse Event Reports & Safety Profile
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
37
Total FAERS Reports
19 (51.4%)
Deaths Reported
12
Hospitalizations
37
As Primary/Secondary Suspect
2
Life-Threatening
Approved Prior to Jan 1, 1982
FDA Approved
Prescription
Status
FDA Application: 011961 ·
First Report: 20120425 · Latest Report: 20180901
What Are the Most Common ISOCARBOXAZID Side Effects?
#1 Most Reported
Completed suicide
15 reports (40.5%)
#2 Most Reported
Toxicity to various agents
6 reports (16.2%)
#3 Most Reported
Serotonin syndrome
4 reports (10.8%)
All ISOCARBOXAZID Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Completed suicide | 15 | 40.5% | 15 | 7 |
| Toxicity to various agents | 6 | 16.2% | 6 | 3 |
Who Reports ISOCARBOXAZID Side Effects? Age & Gender Data
Gender: 72.2% female, 27.8% male. Average age: 44.4 years. Most reports from: US. View detailed demographics →
Is ISOCARBOXAZID Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 2 | 2 | 2 |
| 2013 | 2 | 0 | 0 |
| 2015 | 1 | 0 | 0 |
| 2016 | 5 | 4 | 2 |
| 2018 | 1 | 0 | 1 |
What Is ISOCARBOXAZID Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 15 |
| Depression | 14 |
Official FDA Label for ISOCARBOXAZID
Official prescribing information from the FDA-approved drug label.